Related Experiment Video
Updated: Jul 18, 2025
09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
30.3K
Antiviral Drugs for Viral Pneumonia
1Department of Intensive Care and Medicine, Gurugram, Haryana, India.
Summary
This review explores antiviral drugs for treating viral pneumonia, highlighting their crucial role in managing severe respiratory infections and improving patient outcomes in critical care settings.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pharmacology
Background:
- Viral pneumonia is a significant cause of respiratory illness and mortality.
- Effective treatment strategies, particularly antiviral medications, are essential for managing severe cases.
- The Indian Journal of Critical Care Medicine publishes research relevant to critical care and infectious disease management.
Purpose of the Study:
- To review the current landscape of antiviral drugs used in the treatment of viral pneumonia.
- To discuss the efficacy and application of these agents in critical care settings.
- To provide an overview of the role of antiviral therapy in improving outcomes for patients with viral pneumonia.
Main Methods:
- Literature review of studies on antiviral drugs for viral pneumonia.
- Analysis of clinical trial data and case reports.
- Synthesis of information on drug mechanisms, efficacy, and safety.
Main Results:
- Several antiviral agents show promise in treating specific viral pneumonias.
- Early initiation of antiviral therapy is often associated with better outcomes.
- Drug resistance and side effects remain important considerations.
Conclusions:
- Antiviral drugs are a vital component of managing viral pneumonia in critical care.
- Further research is needed to optimize treatment protocols and develop new agents.
- Personalized treatment approaches based on viral etiology and patient factors are recommended.
Related Concept Videos
01:28Pneumonia IV: Management
359
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359
01:30Pneumonia V: Nursing management and Prevention
2.2K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.2K
01:17Drugs Used in Lower Respiratory Disorders: Overview
487
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
487
01:16Drugs Used in Upper Respiratory Disorders: Overview
290
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
290
01:30Pneumonia III: Complications and Assessment
261
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
261
01:30Pneumonia I: Introduction
268
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
268